1. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223): 507-13. doi:10.1016/S0140-6736(20)30211-7 PMid:32007143

2. Maleki A, Hosseini M, Hamed Chaman N. Protective Effects of Resistance Training and Biotin Supplementation in Modulating Symptoms and Increasing Humoral Immunity Levels in Men Recovered from Acute Respiratory Syndrome After Coronavirus-2. Paramed Sci Mil Health. 2023; 17 (4): 4-17.

3. Hashemieh M. Epidemiology, transmission methods, clinical manifestations, radiological symptoms, prognosis and treatment of COVID-19 in children. J Arak Univ Med Sci. 2020;23(5):654-65.

4. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020; 395(10226):809-15. doi:10.1016/S0140-6736(20)30360-3 PMid:32151335

5. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497-506. doi:10.1016/S0140-6736(20)30183-5 PMid:31986264

6. Wang Z, Chen X, Lu Y, Chen F, Zhang W. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends. 2020; 14(1):64-8. doi:10.5582/bst.2020.01030 PMid:32037390

7. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. doi:10.1001/jama.2020.1585 PMid:32031570 PMCid:PMC7042881

8. Zhang J, Zhang X, Liu J, Ban Y, Li N, Wu Y, et al. Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing. Int Immunopharmacol. 2020; 88: 106861. doi:10.1016/j.intimp.2020.106861 PMid:32795836 PMCid:PMC7410803

9. Wu MY, Yao L, Wang Y, Zhu Xy, Wang XF, Tang PJ, Chen C. Clinical evaluation of potential usefulness of serum lactate dehydrogenase (LDH) in 2019 novel coronavirus (COVID-19) pneumonia. Respir Res. 2020; 21:1-6. doi:10.1186/s12931-020-01427-8 PMid:32503593 PMCid:PMC7271471

10. Li C, Ye J, Chen Q, Hu W, Wang L, Fan Y, et al. Elevated lactate dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19. Aging (Albany NY). 2020; 12(15):15670. doi:10.18632/aging.103770 PMid:32780700 PMCid:PMC7467418

11. Trovas G, Tournis S. Vitamin D and COVID-19. Hormones. 2021; 20(1): 207-8. doi:10.1007/s42000-020-00265-z PMid:33410090 PMCid:PMC7788458

12. Da Silveira MP, da Silva Fagundes KK, Bizuti MR, Starck É, Rossi RC, de Resende E Silva DT. Physical exercise as a tool to help the immune system against COVID-19: an integrative review of the current literature. Clin Exp Med. 2021; 21(1):15-28. doi:10.1007/s10238-020-00650-3 PMid:32876819 PMCid:PMC7465331

13. Aghababa A, Zamani Sani SH, Rohani H, Nabilpour M, Badicu G, Fathirezaie Z, et al No evidence of systematic change of physical activity patterns before and during the Covid-19 pandemic and related mood states among Iranian adults attending team sports activities. Front Psychol. 2021; 12: 641895. doi:10.3389/fpsyg.2021.641895 PMid: 34025513 PMCid:PMC8134620

14. Halabchi F, Ahmadinejad Z, Selk-Ghaffari M. COVID-19 epidemic: exercise or not to exercise; that is the question! Acta Med Iran. 2020; 58(7): 1-3.

15. Peake JM, Neubauer O, Della Gatta PA, Nosaka K. Muscle damage and inflammation during recovery from exercise. J Appl Physiol. 2017; 122(3): 559-70. doi:10.1152/japplphysiol.00971.2016 PMid:27932676

16. Nabatchian F, Keramati S. Crocin As A Bio molecule. Lab Diagn. 2023; 15(59):54-67.

17. 17. Husaini AM, Jan KN, Wani GA. Saffron: A potential drug-supplement for severe acute respiratory syndrome coronavirus (COVID-19) management. Heliyon. 2021; 7(5): e07068. doi:10.1016/j.heliyon.2021.e07068 PMid: 34027196 PMCid:PMC8132610

18. Bashir H, Kumhar SH, Qadir W. Effect of Crocus sativus (saffron) on corona virus. World J Pharm Pharm Sci. 2021; 10: 860-76.

19. Mentis A-FA, Dalamaga M, Lu C, Polissiou MG. Saffron for “toning down” COVID-19-related cytokine storm: Hype or hope? A mini-review of current evidence. Metab Open. 2021;11:100111. doi:10.1016/j.metop.2021.100111 PMid: 34341766 PMCid:PMC8319249

20. Sarraf S, Vahid D, Sasan A, Ramin D, Khor H. The effect of combined exercise and flaxseed supplementation on insulin indices and body composition in overweight women. Iran J Gynecol Obstet Infertil. 2018;21(8):9-21.

21. Begi I, Afzalpour M, Ismaeil M, Yousefi M, Faizi T. The short-term effect of saffron extract consumption on the serum levels of interleukin-6, tumor necrosis factor alpha and cortisol in young men after an intense exercise session. Appl Stud Biol Sci Sports. 2022.

22. A G, Z HK. The Simultaneous Effect of Four Weeks of Nigella Sativa Oil Supplementation and Aerobic Exercise on Some Stress and Growth Factors of Inactive Young Women. CMJA. 2023; 13(2):41-9.

23. Akbar MA, Gholamreza BK, Golnush H, Dariush V. Medicinal plants effective in treating coronavirus. 2021.

24. 24. Elnaz H, Shamsali R, Fazel SS, Reza D, Jalal ZQM. A review of the therapeutic and phytochemical properties of fenugreek.

25. Zohreh I, Mahmud EA, Goodarz A, Pourandokt D, Khosrow P. Identification of chemical compounds and investigation of the antibacterial effect of peppermint essential oil on a number of microbial strains.

26. Kazem SS, Saideh S, Zahra D, Mehta MN. Investigation of the antimicrobial activity of ethanolic extracts of black pepper (Piper nigrum) and Peganum harmala (Peganum harmala) against antibiotic-resistant strains of Staphylococcus aureus.

27. Nancy RG, Aurelio LM, Enrique P, Nelly RC, Teresa J. Antimicrobial Activity and Physicochemical Characterization of Oregano, Thyme and Clove Leave Essential Oils, Nonencapsulated and Nanoencapsulated, Using Emulsification. 2019.

28. Tavakoli S, Mokhtarian M. Effects of green tea extract and vitamin D to combat with the COVID-19 pandemic disease. J Halal Res. 2022; 5(2): 1-1.

29. Payvar B, Azami S, Khodadadegan MO, Saburi E, Sahab Negah S, Hajali V. Clinical Symptoms of COVID-19 Patients Admitted to Hazrat Musa Ibne Jafar Hospital in Quchan City. Navid No. 2022; 25(83): 11-7.

30. Taghavi MR, Karamouz Mashhadi MH, Poorbarat S, Khoshdel E, Younessi Heravi MA. Evaluation of the Effect of Ionic Plasma Cluster Technology on the Improvement of Symptoms in Patients with COVID-19. J Isfahan Med Sch. 2024; 42(771): 489-96.

31. Mahmoodi S, Yousefi M, Sadeghi O, Mahmoodabadi A, Sadriirani M, Hosseinzade Z, et al. Green tea intake and its effect on laboratory parameters and disease symptoms in hospitalised patients with Covid 19: a structured protocol for a randomized controlled trial. Trials. 2021; 22(1):514. doi:10.1186/s13063-021-05484-2 PMid:34380533 PMCid:PMC8356447

32. Gooruee R, Pahlavani N, Hadi V, Hadi S. Effect of Kefir Produced from Cow Milk on Clinical Outcomes and Immune Response of Patients with COVID-19: A Randomized Clinical Trial. Ann Mil Health Sci Res. 2022; 20(4).

33. Biesalski HK. Vitamin D deficiency and co-morbidities in COVID-19 patients–A fatal relationship? NFS J. 2020;20:10-21. doi:10.1016/j.nfs.2020.06.001 PMid:32834941 PMCid:PMC7280358

34. Martineau AR, Forouhi NG. Vitamin D for COVID-19: a case to answer? Lancet Diabetes Endocrinol. 2020;8(9):735-6. doi:10.1016/S2213-8587(20)30268-0 PMid:32758429 PMCid:PMC7398646

35. Ali N. Role of vitamin D in preventing of COVID-19 infection, progression and severity. J Infect Public Health. 2020; 13(10): 1373-80. doi:10.1016/j.jiph.2020.06.021 PMid: 32605780 PMCid:PMC7289568

36. Tan CW, Ho LP, Kalimuddin S, Cherng BPZ, Teh YE, Thien SY, et al. A cohort study to evaluate the effect of combination Vitamin D, Magnesium and Vitamin B12 (DMB) on progression to severe outcome in older COVID-19 patients. MedRxiv. 2020:2020.06.01.20112334. doi:10.1101/2020.06.01.20112334

37. Teymoori‐Rad M, Marashi SM. Vitamin D and Covid‐19: from potential therapeutic effects to unanswered questions. Rev Med Virol. 2021; 31(2):e2159. doi:10.1002/rmv.2159 PMid:33051969 PMCid:PMC7646023

38. Tavakoli S, Mokhtarian M. Effects of green tea extract and vitamin D to combat with the COVID-19 pandemic disease. J Halal Res. 2022; 5(2):1-11.

39. Serrano-Lorenzo P, Coya ON, López-Jimenez A, Blázquez A, Delmiro A, Lucia A, et al. Plasma LDH: A specific biomarker for lung affectation in COVID-19? Pract Lab Med. 2021; 25:e00226. doi:10.1016/j.plabm.2021.e00226 PMid: 33898695 PMCid:PMC8056754

40. Fialek B, Pruc M, Smereka J, Jas R, Rahnama-Hezavah M, Denegri A, et al. Diagnostic value of lactate dehydrogenase in COVID-19: A systematic review and meta-analysis. Cardiol J. 2022; 29(5): 751-8. doi:10.5603/CJ.a2022.0056 PMid:35849131 PMCid:PMC9559248

41. Qiu P, Zhou Y, Wang F, Wang H, Zhang M, Pan X, et al. Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis. Aging Clin Exp Res. 2020; 32: 1869-78. doi:10.1007/s40520-020-01664-3 PMid:32749558 PMCid:PMC7402285

42. Kashefizadeh A, Ohadi L, Golmohammadi M, Araghi F, Dadkhahfar S, Abedini A, et al. Clinical features and short-term outcomes COVID-19 in Tehran, Iran: An analysis of mortality and hospital stay. Acta Biomed. 2020; 91(4). doi:10.23750/abm.v91i4.10354 PMid:33525296 PMCid:PMC7927575